-
Docosahexaenoic Acid: Hippocampal Research Workflows
2026-09-14
Docosahexaenoic Acid (DHA) enables experiments that connect membrane lipid remodeling with oxidative stress, synaptic structure, and cognitive outcomes. This workflow translates hippocampal spatial metabolomics findings into practical cell, tissue, and translational research strategies.
-
PPM-18: iNOS and NF-κB Inhibition
2026-09-14
PPM-18, also called N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, is a synthetic naphthoquinone derivative studied as an inhibitor of inducible nitric oxide synthase expression. Its reported activity connects NF-κB signaling pathway inhibition with reduced nitric oxide-associated inflammatory readouts in cell and rodent models.
-
Biotin-tyramide for Reliable Spatial Assays
2026-09-13
Learn how Biotin-tyramide (SKU A8011) supports enzyme-mediated signal amplification in immunohistochemistry and in situ hybridization workflows that complement cell viability, proliferation, and cytotoxicity assays. The guide emphasizes solvent handling, controls, interpretation, and practical vendor-selection criteria.
-
Cyclosporin A (B1922): Practical Lab Workflow
2026-09-12
Cyclosporin A (B1922) supports controlled cyclophilin and calcineurin-NFAT pathway studies in biochemical and cellular models, including immune activation, apoptosis modulation, and mitochondrial function. It should be prepared in an organic solvent rather than water, with solvent-matched controls and model-specific dose validation; the product should not be treated as a ready-made aqueous reagent or a clinical dosing reference.
-
ANKLE2 Promotes Zika Virus Replication
2026-09-11
Fishburn and colleagues show that the microcephaly-associated host protein ANKLE2 acts as a proviral factor for Zika virus by supporting virus-induced endoplasmic reticulum remodeling. The effect extends to mosquito cells and other orthoflaviviruses, linking ANKLE2-dependent membrane organization with viral replication and immune evasion.
-
Stabilizing LNP Self-Replicating RNA Vaccines
2026-09-11
The reference study systematically examines how temperature, buffer composition, cryoprotection, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Its central finding is that an RNase-free PBS formulation containing 10% (w/v) sucrose preserved structural integrity and in vivo potency at −20 °C for 30 days, while lyophilization also retained bioactivity under the tested conditions.
-
Dinaciclib Synthetic Lethality in VHL-Deficient RCC
2026-09-10
The reference study identifies a selective vulnerability in clear cell renal cell carcinoma (CC-RCC): loss of VHL increases dependence on cell-cycle-associated survival programs that can be disrupted by the CDK inhibitor Dinaciclib. Using cellular assays and an orthotopic patient-derived xenograft model, the authors show activity against both CD105-positive cancer stem cells and CD105-negative tumor cells while defining important limits related to proliferation state and genotype.
-
SB 431542: Practical ALK5 Inhibitor Workflows
2026-09-10
SB 431542 enables controlled interrogation of ALK5-driven TGF-β signaling, from Smad2 phosphorylation assays to CD44 regulation in breast cancer stem-like cells. Its value is strongest when pathway inhibition is paired with orthogonal genetic, phenotypic, and immune readouts rather than used as a standalone cytotoxicity test.
-
Cefodizime in Translational Infection Models
2026-09-09
Cefodizime offers translational researchers a mechanistically defined way to connect penicillin-binding protein inhibition, antimicrobial resistance surveillance, host-response biology, and exposure-aware infection modeling.
-
MDL 28170: A Practical Calpain Inhibitor Workflow
2026-09-09
MDL 28170 is a membrane-permeable calpain inhibitor designed for mechanistic studies spanning hippocampal injury, apoptosis assay workflows, and cysteine-protease biology. Its brain penetration, nanomolar biochemical potency, and activity against both calpain and cathepsin B make it useful for target-engagement experiments, provided researchers separate calpain-specific conclusions from broader cysteine-protease effects.
-
Hexamethonium Bromide in Autonomic Signaling
2026-09-08
Hexamethonium Bromide enables functional interrogation of autonomic ganglia by selectively interrupting neuronal nicotinic acetylcholine receptor signaling. This guide translates sex-aware hypertension findings into practical telemetry, ex vivo, and troubleshooting workflows without confusing ganglionic blockade with a complete measure of sympathetic activity.
-
Gentamycin Sulfate in Resistance Research
2026-09-08
Learn how to use Gentamycin Sulfate to connect ribosome inhibition with susceptibility testing, plasmid analysis, and carbapenemase transmission studies. The workflow emphasizes orthogonal validation so a gentamycin phenotype is not mistaken for proof of a specific resistance gene.
-
CA-074 Me in Lysosomal Cell Death Research
2026-09-07
CA-074 Me enables cell-permeable interrogation of cathepsin B during lysosomal membrane permeabilization, necroptosis, and apoptosis assays. Its strongest advantage is mechanistic placement: researchers can test whether cathepsin B is a downstream driver rather than merely a marker of lysosomal damage.
-
Calpain, BDNF/TrkB, and Offspring Cognition
2026-09-07
A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy to later offspring cognitive impairment through excessive calpain activity and suppression of hippocampal BDNF/TrkB signaling. Postnatal treatment with the calpain inhibitor MDL 28170 or the TrkB agonist 7,8-DHF partially rescued molecular, structural, and behavioral deficits, supporting calpain–TrkB dysregulation as a mechanistic target for neuroprotection research.
-
Omega-3 PUFAs Protect Against Cisplatin Nephrotoxicity
2026-09-05
The reference study shows that combined EPA and DHA protect mice and renal tubular epithelial cells from cisplatin-induced injury more effectively than either fatty acid alone. Its mechanistic contribution is the linkage of p62-Keap1-Nrf2 antioxidant signaling with MDM2-p53 apoptosis control, including reduced inflammation and chronic renal fibrosis after repeated CDDP exposure.